Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR7237Referred to Committee

Chemical Abortion Risk Awareness Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-01-23
Introduced
1
Cosponsors
HR
ⓘ
Type

Sponsor

Marlin A. Stutzman
Marlin A. Stutzman
Republican · IN · Representative
Votes with party: 97.6% (541 recorded votes)

Full profile: /officials/S001188

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Diana Harshbarger (R-TN-1)Original· 2026-01-23

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-01-23

Source: Congress.gov

Plain-English Summary

This bill would require doctors to inform patients about the risks associated with medication-based abortion before providing the drugs, and would establish reporting requirements for any serious complications that occur. The measure would affect women seeking abortion care and healthcare providers who administer these medications. Supporters argue it increases informed consent, while opponents contend it could create barriers to accessing abortion services.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR8278Fostering the Use of Technology to Uphold Regulatory Effectiveness in Supervision Act
    Referred to Committee · 2026-05-13
  • HR8155Foreign Propaganda Transparency Act
    Referred to Committee · 2026-03-27
  • HR8090To require the Federal Deposit Insurance Corporation and the National Credit Union Administration to carry out an analysis to determine whether insurance coverage should be raised on covered transaction accounts, and for other purposes.
    Referred to Committee · 2026-03-25
  • HR7586American Families First Act
    Referred to Committee · 2026-03-02